Structured abstract for full paper Background After recovery from COVID-19, most patients
have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an …

In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care
to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-…

Combined fecal microbiota transfer and antibiotic treatment prevented recurrences of urinary
tract infections with multidrug-resistant (MDR) Pseudomonas aeruginosa, but it failed to …

Objective To compare survival of individuals with coronavirus disease 2019 (COVID-19)
treated in hospitals that either did or did not routinely treat patients with hydroxychloroquine or …

ObjectiveTo compare survival of subjects with COVID-19 treated in hospitals that either did
or did not routinely treat patients with hydroxychloroquine or chloroquine. MethodsWe …

Background Lemierre's syndrome is a rare disease with different clinical and microbiological
criteria. Without adequate treatment mortality is high. It often concerns healthy adolescents …

Objectives: To illustrate that the protease inhibitor (PI) ritonavir, widely used as part of the
treatment for HIV, might cause drug–drug interactions with inhaled corticosteroids. Material and …

OBJECTIVE: High-flow nasal oxygen (HFNO) therapy is frequently applied outside ICU setting
in hypoxemic patients with COVID-19. However, safety concerns limit more widespread …

Convalescent plasma is plasma collected from individuals after resolution of an infection
and the development of antibodies. Passive antibody administration by transfusion of …

… the median of the remaining observers were either substantial (n = 4) or moderate (n = 4). …
, but this occurred in a small subset of patients (n = 5). In this multidisciplinary decision, the …